Filing Details

Accession Number:
0000711377-17-000048
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-20 21:03:12
Reporting Period:
2017-11-17
Accepted Time:
2017-11-20 21:03:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-17 5,700 $39.61 27,212 No 4 M Direct
Common Stock Acquisiton 2017-11-17 6,124 $47.12 33,336 No 4 M Direct
Common Stock Acquisiton 2017-11-17 6,000 $53.95 39,336 No 4 M Direct
Common Stock Disposition 2017-11-17 17,824 $80.32 21,512 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2017-11-17 5,700 $0.00 5,700 $39.61
Common Stock Common Stock (Right to Buy) Disposition 2017-11-17 6,124 $0.00 6,124 $47.12
Common Stock Common Stock (Right to Buy) Disposition 2017-11-17 6,000 $0.00 6,000 $53.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
71,173 2019-10-31 No 4 M Direct
6,124 2020-11-08 No 4 M Direct
59,049 2021-10-29 No 4 M Direct
Footnotes
  1. Options were granted 10/1/2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
  2. Options were granted 10/8/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
  3. Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant